Skip to main content
main-content

Free registration

Medicine Matters is developed for healthcare professionals as

a premier resource for the latest clinical information in medicine.

Editors' pick

16-08-2018 | Risk factors | Highlight | News

Risk factor control may mitigate excess cardiovascular, mortality risk in type 2 diabetes

A study of the Swedish National Diabetes Register suggests that keeping five cardiovascular risk factor variables within the target ranges could offset the excess risk for death, myocardial infarction, or stroke among patients with type 2 diabetes relative to the general population.

25-06-2018 | SGLT2 inhibitors | Themed collection | Collection

Sodium-glucose cotransporter-2 inhibitors in type 2 diabetes

An updated collection of articles focusing on the mechanism of action and clinical use of sodium-glucose cotransporter-2 inhibitors in patients with diabetes.

15-08-2018 | Neuropathy | Editorial | Article

Are we using the right tests to diagnose diabetic neuropathy?

Uazman Alam and colleagues interrogate current evidence and real-world clinical scenarios to address whether enough is being done with the tools available to screen and diagnose diabetic neuropathy.

Latest from across the site

20-08-2018 | Pregnancy | News

Metformin may not improve pregnancy outcomes for obese women

The authors of a systematic review find insufficient evidence to support the use of metformin to improve pregnancy outcomes among obese women.

Source:

Cochrane Database Syst Rev 2018; 7: CD010564

17-08-2018 | Semaglutide | Highlight | News

Semaglutide shows promise for weight management

Findings from a dose-ranging phase II trial published in The Lancet suggest that semaglutide, in combination with lifestyle intervention, may aid weight loss in people with obesity who do not have diabetes.

Source:

Lancet 2018; doi:10.1016/S0140-6736(18)31773-2
Lancet 2018; doi:10.1016/S0140-6736(18)31826-9

16-08-2018 | Risk factors | Highlight | News

Risk factor control may mitigate excess cardiovascular, mortality risk in type 2 diabetes

A study of the Swedish National Diabetes Register suggests that keeping five cardiovascular risk factor variables within the target ranges could offset the excess risk for death, myocardial infarction, or stroke among patients with type 2 diabetes relative to the general population.

Source:

N Engl J Med 2018; 379: 633–644, 684–685

Meet our UK Advisory Board

New Content Item Meet our international Editorial Board

image credits